Wedbush reaffirmed their outperform rating on shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in a report issued on Saturday. Wedbush currently has a $800.00 price target on the stock.

A number of other brokerages also recently weighed in on ISRG. Canaccord Genuity upped their price objective on shares of Intuitive Surgical from $750.00 to $800.00 and gave the stock a buy rating in a research report on Wednesday, October 19th. RBC Capital Markets set a $760.00 price objective on shares of Intuitive Surgical and gave the stock a hold rating in a research report on Wednesday, October 19th. Royal Bank Of Canada upped their price objective on shares of Intuitive Surgical from $750.00 to $760.00 and gave the stock a sector perform rating in a research report on Wednesday, October 19th. Wells Fargo & Company began coverage on shares of Intuitive Surgical in a research report on Thursday, October 13th. They issued an outperform rating for the company. Finally, Zacks Investment Research downgraded shares of Intuitive Surgical from a buy rating to a hold rating in a research report on Tuesday, September 20th. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and thirteen have given a buy rating to the company’s stock. The stock presently has an average rating of Buy and a consensus target price of $731.97.

Intuitive Surgical (NASDAQ:ISRG) opened at 664.71 on Friday. The stock has a market cap of $25.76 billion, a price-to-earnings ratio of 35.85 and a beta of 0.52. Intuitive Surgical has a 52-week low of $502.01 and a 52-week high of $727.25. The company has a 50-day moving average price of $637.73 and a 200 day moving average price of $672.81.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, October 18th. The company reported $6.19 earnings per share for the quarter, topping analysts’ consensus estimates of $5.13 by $1.06. The business earned $682.90 million during the quarter, compared to the consensus estimate of $650.49 million. Intuitive Surgical had a net margin of 27.51% and a return on equity of 15.02%. The company’s revenue was up 15.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $5.24 earnings per share. On average, analysts expect that Intuitive Surgical will post $22.20 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Intuitive Surgical’s (ISRG) Outperform Rating Reiterated at Wedbush” was first published by Daily Political and is the sole property of of Daily Political. If you are viewing this story on another publication, it was illegally stolen and republished in violation of U.S. and international copyright law. The correct version of this story can be accessed at http://www.dailypolitical.com/2017/01/14/intuitive-surgicals-isrg-outperform-rating-reiterated-at-wedbush.html.

In related news, Director Lonnie M. Smith sold 1,000 shares of the stock in a transaction that occurred on Tuesday, December 13th. The shares were sold at an average price of $650.00, for a total transaction of $650,000.00. Following the completion of the transaction, the director now owns 235,971 shares of the company’s stock, valued at approximately $153,381,150. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Lonnie M. Smith sold 275 shares of the stock in a transaction that occurred on Thursday, November 17th. The stock was sold at an average price of $646.50, for a total transaction of $177,787.50. Following the transaction, the director now directly owns 235,890 shares of the company’s stock, valued at approximately $152,502,885. The disclosure for this sale can be found here. 3.10% of the stock is currently owned by insiders.

Several institutional investors have recently bought and sold shares of ISRG. Calamos Wealth Management LLC bought a new position in Intuitive Surgical during the second quarter worth $999,000. American Century Companies Inc. boosted its position in Intuitive Surgical by 0.7% in the second quarter. American Century Companies Inc. now owns 415,307 shares of the company’s stock worth $274,688,000 after buying an additional 2,854 shares during the last quarter. Candriam Luxembourg S.C.A. boosted its position in Intuitive Surgical by 34.9% in the second quarter. Candriam Luxembourg S.C.A. now owns 1,203 shares of the company’s stock worth $796,000 after buying an additional 311 shares during the last quarter. Retirement Systems of Alabama boosted its position in Intuitive Surgical by 2.7% in the second quarter. Retirement Systems of Alabama now owns 19,404 shares of the company’s stock worth $12,834,000 after buying an additional 508 shares during the last quarter. Finally, Bourne Lent Asset Management Inc. boosted its position in Intuitive Surgical by 4.2% in the second quarter. Bourne Lent Asset Management Inc. now owns 4,961 shares of the company’s stock worth $3,281,000 after buying an additional 200 shares during the last quarter. 90.53% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

5 Day Chart for NASDAQ:ISRG

Receive News & Ratings for Intuitive Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.